Abstract
Mendelian randomization has been previously used to estimate the effects of binary and ordinal categorical exposures - e.g. type 2 diabetes or educational attainment defined by qualification - on outcomes. Binary and categorical phenotypes can be modelled in terms of liability, an underlying latent continuous variable with liability thresholds separating individuals into categories. Genetic variants typically influence an individual’s categorical exposure via their effects on liability, thus Mendelian randomization analyses with categorical exposures will capture effects of liability which act independent of exposure category.
We discuss how groups where the categorical exposure is invariant can be used to detect liability effects acting independently of exposure category. For example, associations between an adult educational attainment polygenic score (PGS) and BMI measured before the minimum school leaving age (e.g. age 10), cannot indicate the effects of years in full-time education on this outcome. Using UK Biobank data, we show that a higher education PGS is strongly associated with lower smoking initiation and higher glasses use at age 15. These associations were replicated in sibling models. An orthogonal approach using the raising of the school leaving age (ROSLA) policy change found that individuals who chose to remain in education to age 16 before the reform likely had higher liability to educational attainment than those who were compelled to remain in education to 16 after the reform, and had higher income, decreased cigarette smoking, higher glasses use and lower deprivation in adulthood. These results suggest that liability to educational attainment associates with health and social outcomes independent of years in full-time education.
Mendelian randomization studies with non-continuous exposures should be interpreted in terms of liability, which may affect the outcome via changes in exposure category and/or independently.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Medical Research Council (MRC) and the University of Bristol support the MRC Integrative Epidemiology Unit [MC_UU_00011/1]. NMD is supported by an Economics and Social Research Council (ESRC) Future Research Leaders grant [ES/N000757/1] and the Norwegian Research Council Grant number 295989. No funding body has influenced data collection, analysis or its interpretation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research has been conducted using the UK Biobank Resource under Application Number 8786.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
This study used individual participant data from the UK Biobank with field IDs listed in the methods section. For details on accessing UK Biobank data please contact access{at}ukbiobank.ac.uk. All summary data are contained in the article or available upon reasonable request.
